BG61705B1 - Метод и състав за определяне имунната активност на биологичноактивни вещества - Google Patents

Метод и състав за определяне имунната активност на биологичноактивни вещества Download PDF

Info

Publication number
BG61705B1
BG61705B1 BG98720A BG9872094A BG61705B1 BG 61705 B1 BG61705 B1 BG 61705B1 BG 98720 A BG98720 A BG 98720A BG 9872094 A BG9872094 A BG 9872094A BG 61705 B1 BG61705 B1 BG 61705B1
Authority
BG
Bulgaria
Prior art keywords
pbl
ttp
cytokines
culture
tested
Prior art date
Application number
BG98720A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG98720A (bg
Inventor
Anna Inglot
Zofia Blach-Olszewska
Original Assignee
Torf Et
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torf Et filed Critical Torf Et
Publication of BG98720A publication Critical patent/BG98720A/bg
Publication of BG61705B1 publication Critical patent/BG61705B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/10—Peat; Amber; Turf; Humus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BG98720A 1991-10-26 1994-04-14 Метод и състав за определяне имунната активност на биологичноактивни вещества BG61705B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91118269A EP0539610A1 (en) 1991-10-26 1991-10-26 Method and composition for determining the immunological activity of solutions containing active substances
PCT/EP1992/002228 WO1993008470A1 (en) 1991-10-26 1992-09-28 Method and composition for determining the immunological activity of bioactive substances

Publications (2)

Publication Number Publication Date
BG98720A BG98720A (bg) 1995-07-28
BG61705B1 true BG61705B1 (bg) 1998-03-31

Family

ID=8207282

Family Applications (1)

Application Number Title Priority Date Filing Date
BG98720A BG61705B1 (bg) 1991-10-26 1994-04-14 Метод и състав за определяне имунната активност на биологичноактивни вещества

Country Status (23)

Country Link
US (1) US5543300A (sk)
EP (2) EP0539610A1 (sk)
JP (1) JPH07500905A (sk)
AT (1) ATE153763T1 (sk)
AU (1) AU678343B2 (sk)
BG (1) BG61705B1 (sk)
CA (1) CA2122131A1 (sk)
CZ (1) CZ100494A3 (sk)
DE (3) DE539610T1 (sk)
DK (1) DK0609255T3 (sk)
ES (1) ES2061424T3 (sk)
FI (1) FI941920A (sk)
GR (3) GR930300100T1 (sk)
HK (1) HK1002610A1 (sk)
HU (1) HU216863B (sk)
LV (1) LV12140B (sk)
NO (1) NO941444L (sk)
PL (1) PL170592B1 (sk)
RO (1) RO114837B1 (sk)
RU (1) RU2125727C1 (sk)
SG (1) SG72665A1 (sk)
SK (1) SK44094A3 (sk)
WO (1) WO1993008470A1 (sk)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19615470A1 (de) * 1996-04-19 1997-10-23 Heinz Beinio Körperpflegemittel und Verfahren zu seiner Herstellung
EP1115408B1 (en) * 1998-09-23 2006-01-25 Pfeinsmith Limited Oxihumic acid and its use in the treatment of various conditions
GB0101973D0 (en) * 2001-01-25 2001-03-14 Statens Seruminstitut Improved in vitro diagnostic method of detecting a cell-mediated immune response
EP1449535B1 (en) * 2003-02-18 2006-05-03 Clinique La Prairie Research SA Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components
US7497947B2 (en) 2004-04-14 2009-03-03 Embro Corporation Devices for water treatment
US7614340B2 (en) * 2007-02-09 2009-11-10 Honeywell International Inc. Composite piston housing for aircraft brakes
US9005449B2 (en) 2011-09-07 2015-04-14 Embro Corporation Use of moss to reduce disinfection by-products in water treated with disinfectants
US9795809B2 (en) 2013-12-23 2017-10-24 Embro Corporation Use of moss to improve dental health
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH636448A5 (en) * 1977-05-06 1983-05-31 Horst Veith Process for the determination of the effect of substances on constituents of the blood for the detection of infectious and immunological processes and composition for carrying it out
NZ214400A (en) * 1985-12-02 1989-05-29 Univ Otago Detecting infection in ruminant including conducting assay of mononuclear cell function
EP0238851B1 (en) * 1986-02-19 1992-12-09 Imreg, Inc. A method and means of assaying an immune system
JP2642112B2 (ja) * 1986-03-06 1997-08-20 コモンウエルス サイエンテイフイック アンド インダストリアル リサーチ オーガナイゼイシヨン 細胞性免疫応答検出用インビトロ分析
US5096708A (en) * 1988-07-07 1992-03-17 Sven Gohla Medical preparation containing as active agent a component from thuja plants which comprises polysaccharides
AU1360492A (en) * 1991-03-16 1992-10-21 Torf Establishment Process for the extraction of peat and apparatus for carrying out the process

Also Published As

Publication number Publication date
DE539610T1 (de) 1993-12-16
RO114837B1 (ro) 1999-07-30
JPH07500905A (ja) 1995-01-26
US5543300A (en) 1996-08-06
DK0609255T3 (da) 1997-12-22
ATE153763T1 (de) 1997-06-15
SG72665A1 (en) 2000-05-23
DE69220078T2 (de) 1997-12-04
EP0539610A1 (en) 1993-05-05
HU216863B (hu) 1999-09-28
CA2122131A1 (en) 1993-04-29
BG98720A (bg) 1995-07-28
LV12140A (lv) 1998-09-20
NO941444L (no) 1994-06-16
ES2061424T3 (es) 1997-10-01
FI941920A0 (fi) 1994-04-25
GR3024457T3 (en) 1997-11-28
HU9401185D0 (en) 1994-07-28
SK44094A3 (en) 1995-03-08
RU94022481A (ru) 1996-09-27
HK1002610A1 (en) 1998-09-04
NO941444D0 (no) 1994-04-21
ES2061424T1 (es) 1994-12-16
AU2650992A (en) 1993-05-21
DE609255T1 (de) 1995-06-14
WO1993008470A1 (en) 1993-04-29
GR940300077T1 (en) 1994-11-30
EP0609255A1 (en) 1994-08-10
DE69220078D1 (de) 1997-07-03
AU678343B2 (en) 1997-05-29
PL170592B1 (en) 1997-01-31
EP0609255B1 (en) 1997-05-28
GR930300100T1 (sk) 1993-10-29
RU2125727C1 (ru) 1999-01-27
FI941920A (fi) 1994-04-25
CZ100494A3 (en) 1994-11-16
HUT69990A (en) 1995-09-28
LV12140B (lv) 1998-12-20

Similar Documents

Publication Publication Date Title
Ytterberg et al. Serum interferon levels in patients with systemic lupus erythematosus
Valle et al. Characteristics of immune interferon produced by human lymphocyte cultures compared to other human interferons
DE3779909T2 (de) In-vitro-testverfahren zum nachweis zellulaerer immunresponsen.
SEKELLICK et al. Chicken interferon types I and II enhance synergistically the antiviral state and nitric oxide secretion
BG61705B1 (bg) Метод и състав за определяне имунната активност на биологичноактивни вещества
Hennes et al. The detection of antibodies to recombinant interferon alfa-2a in human serum
Ferrante et al. Depression of human polymorphonuclear leucocyte function by anti-malarial drugs.
Van Pham et al. Metabolic and functional stimulation of lymphocytes and macrophages by an Escherichia coli extract (OM-89): in vitro studies
Reibnegger et al. The dependence of cell-mediated immune activation in malaria on age and endemicity
Frøland et al. Immunologicai Characterization of Lymphocytes in Lymphoproliferative Diseases. Restriction of Classes, Subclasses, and Gm Allotypes of Membrane‐Bound Ig
Wyler et al. Malaria antigen-specific T-cell responsiveness during infection with Plasmodium falciparum.
Gilles et al. Studies on the Significance of High Serum Gamma-Globulin Concentrations in Gambian Africans: I.—Gamma-Globulin Concentrations of Gambian Children in the First Two Years of Life
DE69007571T2 (de) Peptidfragmente von HIV.
JPH01110633A (ja) 肝細胞刺激因子
Beveridge Babesicidal Effect of Basically Substituted Carbanilides: II: Imidocarb in Rats and Mice: Toxicity and Activity against Babesia rodhaini
US4499093A (en) Interferon induction method
Ingimarsson et al. Immune Reactions and Long‐Term Therapy with Human Leukocyte Interferon
Vervliet et al. Interferon production by cultured peripheral leucocytes of MS patients.
Torre et al. Increased levels of nitrite in the sera of children infected with human immunodeficiency virus type 1
Heremans et al. Interferon induced in mouse spleen cells by Staphylococcus aureus
Gilles et al. Studies on the Significance of High Serum Gamma-Globulin Concentrations in Gambian Africans: III.—Gamma-Globulin Concentrations of Gambian Women Protected from Malaria for Two Years
Okoli et al. Responses of selected inflammatory, kidney and liver function markers in serum of Nigerian children with severe falciparum malaria to treatment with artesunate/artemether-lumefantrine combination therapy
Trager Effect of drugs on the folic and folinic acid contents of erythrocytes infected with malaria parasites
Baron 37. Interferon: Production, Assay, and Characterization
ABDEL ALL Haematological and biochemical studies on the efficacy of synanthic against gastro-intestinal parasites in sheep